Feasibility of Using Hydrogel Spacers for Borderline-Resectable and Locally Advanced Pancreatic Tumors.
Where this comes from
- Record sourced from PubMed, PMID 31306631.
- Also identified by DOI 10.1053/j.gastro.2019.07.012 and PMC identifier 7263852.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This article has an accompanying continuing medical education activity, also eligible for MOC credit, on page e14 (https://www.gastrojournal.org/cme/home). Learning Objective: Upon completion of this CME activity, successful learners will be able to describe the pharmacokinetics of hydrogel, identify appropriate candidates for hydrogel injection among patients with pancreatic cancer, and describe key techniques to successfully inject hydrogel as well as the histopathologic findings associated with hydrogel.
Medical subject headings
- Carcinoma, Pancreatic Ductal
- Duodenum
- Pancreatic Neoplasms
- Polyethylene Glycols
- Radiation Injuries
- Radiosurgery